Discover how metrology supports recycling, sustainable materials and circular economy goals through precise measurement ...

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...

Researchers have developed a program that simulates human and animal cell behavior, creating digital models of tissues and ...

Health workers on the frontline of drug recovery have told Sky News that the UK faces a tidal wave of problems if more isn't ...

Both the Mediterranean diet and the “brain-healthy” MIND Diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) — ...

Gene Mack, CEO, GAIN Therapeutics, outlines how early trial results for GT-02287 are shaping the company’s strategy for ...

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and the neonatal Fc receptor (FcRn). FcRn is central to the body’s ability to ...

Danish researchers followed 1.2 million children and found aluminum in vaccines did not cause autism, asthma, autoimmune ...

The dulaglutide biosimilar LY05008 demonstrated equivalent efficacy in reducing HbA1c, along with comparable safety and immunogenicity profiles, to the reference drug dulaglutide in Chinese adults ...

Clarametyx Biosciences announced that CMTX-101, a monoclonal antibody designed to collapse bacterial biofilms, will receive ...